ArticleHematology, transfusion and cell therapy

Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report.

Renato Centrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.